Twenty-three companies in the healthcare sector reported their earnings in the week ended February 6, bringing the sector’s overall reporting progress to 38% so far this quarter.
This week, the Health Care Select Sector SPDR Fund ETF (XLV) declined 0.55%. On a year-to-date basis, XLV has risen 1.18% compared to a 1.27% rise in the S&P 500 index.
Earnings Recap
Among the companies that reported their results this week, one missed earnings estimates while 22 topped consensus. A similar trend was seen on the revenue side.
Pfizer (PFE) posted a strong Q4 print, beating both the top and bottom lines. It reported earnings of $0.66 on revenue of $17.6B. However, the company’s shares fell after it indicated revenue contraction for 2026 amid a nearly $1.5B impact attributed to some of its products facing loss of market exclusivity.
AbbVie (ABBV) also posted a better-than-expected result, with revenue of $16.62B and earnings per share of $2.71, as the company’s former best seller, Humira, exceeded Street forecasts, offsetting a mixed performance from its newer immunology drugs, Rinvoq and Skyrizi. The company’s 2026 profit guidance also topped Wall Street estimates. It sees total sales growth of 9.5% for the full year, backed by blockbuster launches.
Merck’s (MERK) shares slid after the drugmaker issued a full-year 2026 outlook below Wall Street expectations, despite a solid fourth quarter. The company posted an EPS of $2.04 and revenue of $16.4B, both of which beat analysts’ consensus.
At an industry level, 4 pharmaceutical companies, 3 biotechnology companies, and 2 managed healthcare firms released their quarterly reports this week. 10 were from the health care equipment, health care facilities, health care services, and health care distributors industries, while 4 were life sciences tools and services firms.
Out of the 35 companies that have reported earnings quarter-to-date, 88.57% topped earnings forecasts, while 82.86% reported revenue above analysts’ estimates.
Gilead Sciences (GILD) and CVS Health (CVS) are the major companies reporting earnings next week.